Karoo Health Names Angela Breton Chief Commercial Officer
Karoo Health, a cardiovascular technology company, said on Oct. 6, 2026 that it appointed Angela "Angie" Breton as Chief Commercial Officer, a newly created role on its executive leadership team. According to the company's announcement, Breton will focus on developing partnerships across healthtech; Karoo said her career spans 25 years as a revenue and commercial growth leader scaling payer, provider, and healthtech platforms.
The appointment follows Karoo's stated closing in July of a $16.2 million Series A financing round co-led by 7wire Ventures and Allumia Ventures, with participation from other investors, according to the company. Karoo CEO Ian Koons said the company is scaling its operations and cited demand for solutions addressing cardiac spend; Breton said she was drawn to the team's work on cardiac care problems and its reported results for payers, providers, and patients.
Karoo describes itself as building an operating system for cardiovascular care that connects clinical, claims, pharmacy, and patient data for earlier risk detection, coordinated care, improved outcomes, and lower costs. These are the company's own claims; the announcement reports no clinical trial, sample size, endpoint, or follow-up data.
**Why it matters:** The hire signals continued commercial build-out among cardiovascular technology vendors positioning data integration and care coordination for payers and providers, a segment attracting venture backing as cardiac spend draws attention.